Evidence map›Paper›PMID 36179506›Full record

ArticleDrug and alcohol dependence2022

Assessment of dependence potential and abuse liability of Δ

S O Vanegas, A M Reck, C E Rodriguez, J A Marusich, O Yassin, G Sotzing, J L Wiley, S G Kinsey

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Drug and alcohol dependence, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Derivation of a health-based guidance value for ΔEFSA journal. European Food Safety Authority · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Evaluation of cannabimimetic effects of selected minor cannabinoids and Terpenoids in mice.Progress in neuro-psychopharmacology & biological psychiatry · 2024
    Article
  6. Differential disruption of response alternation by precipitated ΔPharmacology, biochemistry, and behavior · 2024
    Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

S O VanegasSchool of Nursing, University of Connecticut, Storrs, CT, USA; Department of Psychological Sciences, University of Connecticut, Storrs, CT, USA.
A M ReckSchool of Nursing, University of Connecticut, Storrs, CT, USA; Department of Psychological Sciences, University of Connecticut, Storrs, CT, USA.
C E RodriguezSchool of Nursing, University of Connecticut, Storrs, CT, USA; Department of Psychological Sciences, University of Connecticut, Storrs, CT, USA.
J A MarusichRTI International, Research Triangle Park, NC, USA.
O Yassin3BC, Inc., Farmington, CT, USA.
G SotzingDepartment of Chemistry, University of Connecticut, Storrs, CT, USA; 3BC, Inc., Farmington, CT, USA.
J L WileyRTI International, Research Triangle Park, NC, USA.
S G KinseySchool of Nursing, University of Connecticut, Storrs, CT, USA; Department of Psychological Sciences, University of Connecticut, Storrs, CT, USA. Electronic address: steven.kinsey@uconn.edu.
University of Connecticut · USRTI International · US

Funding

Minor Cannabinoids and Terpenes: Preclinical Evaluation as AnalgesicsR01AT010773 · NCCIH · UPSTATE MEDICAL UNIVERSITY · PI GAMAGE, THOMAS F · 2019 to 2024
$2.5M
The role of RGS12 in differential modulation of G protein versus beta-arrestin signaling downstream of the kappa opioid receptorR01DA048153 · NIDA · UNIVERSITY OF NORTH TEXAS HLTH SCI CTR · PI SIDEROVSKI, DAVID P. · 2021 to 2025
$1.8M
Stemming the opioid-induced pain cascade via cannabinoid modulationR21DA052690 · NIDA · UNIVERSITY OF CONNECTICUT STORRS · PI KINSEY, STEVEN G. · 2021 to 2022
$443k
Reducing the deleterious effects of synthetic cannabinoid withdrawal on emotionality and motivationR03DA039335 · NIDA · WEST VIRGINIA UNIVERSITY · PI KINSEY, STEVEN G. · 2018 to 2019
$150k
NCCIH NIH HHS R01 AT010773NIDA NIH HHS R01 DA048153NIDA NIH HHS R03 DA039335NIDA NIH HHS R21 DA052690
6 · The paper itself

Abstract

Delta-8-tetrahydrocannabinol (Δ

Indexed as

CannabidiolCannabinoidsAnimalsBenzoxazinesCalcium CarbonateDronabinolMiceMice, Inbred C57BLMorpholinesNaphthalenesPiperidinesPyrazolesReceptor, Cannabinoid, CB1Rimonabant(3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanoneBenzoxazinesCalcium CarbonateCannabidiolCannabinoidsDronabinolMorpholinesNaphthalenesPiperidinesPyrazolesReceptor, Cannabinoid, CB1RimonabantCannabis use disorderDrug dependenceMinor phytocannabinoidSubstance use disorder

Identifiers

PMID36179506
PMCPMC10288383
OpenAlexW4296520303

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.